IMMP
Immutep Limited
NASDAQ · Healthcare · Biotechnology · AU
$0.36
−0.05%Margins
Gross margin
-402.9%
EBITDA margin
-674.1%
EBIT margin
-977.2%
Net margin
-651.0%
FCF margin
-550.7%
-229.5%
Return on equity
-169.6%
Return on assets
-338.7%
Return on invested capital
0.19x
Asset turnover
-$85.9M
Cash from operations
$0.34
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026